Yahoo Web Search

  1. Yahoo Finance Results

  2. Don’t Sell Bristol-Myers Squibb Company (NYSE:BMY) Before You Read This

    Simply Wall St. via Yahoo FinanceNov 27 14:19 PM

    To keep it practical, we’ll show how Bristol-Myers Squibb Company’s (NYSE:BMY) P/E ratio could help you assess the value on offer. Bristol-Myers Squibb ...

  3. Better Buy: Pfizer vs. Bristol-Myers Squibb

    Motley Fool via Yahoo FinanceNov 25 16:30 PM

    Frenemies might be one of those annoying word mash-ups, but the term definitely describes the relationship between two of the biggest drugmakers on the planet: Pfizer (NYSE: PFE) and Bristol ...

  4. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.

  5. BMY credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.

  6. Bristol-Myers Squibb Co said on Monday a combination of two of its cancer drugs, being tested as a maintenance therapy, did not meet the main goal of extending the lives ...

  7. Bristol-Myers Squibb Co said on Monday a combination of two of its cancer drugs, being tested as a maintenance therapy, did not meet the main goal of extending the lives ...

  8. Bristol-Myers Squibb Company BMY announced that the phase III CheckMate-451 study on immuno-oncology drug Opdivo in combination with Yervoy was unsuccessful. The ...

  9. Here's a roundup of top developments in the biotech space over the last 24 hours. Emergent Biosolutions Inc (NYSE: EBS) Vericel Corp (NASDAQ: VCEL) Aduro BioTech Inc (NASDAQ: ADRO) Aerpio Pharmaceuticals ...

  10. ARCH and Bristol-Myers Squibb Company BMY. This optimism largely stems from the Santa Claus rally, which is being felt way ahead of Christmas.

  11. What Happened in the Stock Market Today

    Motley Fool via Yahoo FinanceNov 27 21:56 PM

    Lung cancer trial flop hits Bristol-Myers Shares of Bristol-Myers Squibb fell 3% after the company announced the failure of a lung cancer drug trial ...